相关实验视频

Updated: Jul 5, 2025

Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions

Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions

Published on: August 2, 2018

在人类内皮细胞和癌细胞中调节HIF开关的规定

Jakub Slawski¹, Maciej Jaśkiewicz², Anna Barton¹

¹Department of Biophysics, Faculty of Biotechnology, University of Wroclaw, Wroclaw, Poland.

European journal of cell biology

|January 23, 2024

概括

低氧诱导因子 (HIF) 通过切换基因表达来调节低氧期间的细胞存活率. 这种HIF开关机制在正常细胞和癌细胞中至关重要,具有治疗潜力.

科学领域:

细胞生物学细胞生物学
分子生物学分子生物学
生物化学生物化学

背景情况:

低氧诱导因子 (HIF) 是关键的转录因子,使细胞能够适应低氧 (低氧) 和氧化应激.
HIFs重编程细胞代谢向糖解,这对于严重缺氧下生存至关重要,影响正常和癌细胞.
从急性缺氧转变为慢性缺氧涉及HIF表达的转变 (HIF-1到HIF-2/HIF-3),称为HIF开关,在癌症和内皮细胞中观察到.

研究的目的:

阐明人类内皮和癌细胞中HIF开关背后的分子机制.
在HIF开关期间调查HIF-α链mRNA和蛋白质水平的差异调节.
探索HIF途径在正常与瘤细胞存活中的不同作用,并确定治疗点.

主要方法:

对HIF-α子单元的mRNA和蛋白质表达水平的分析.
在人类内皮细胞和癌细胞模型中的比较研究.
研究细胞对不同氧气条件的反应.

主要成果:

该研究详细介绍了控制HIF开关的机制,涉及HIF-alpha链的差异表达.
观察到HIF-1和HIF-2/HIF-3表达之间的过渡是关键的生存适应.
在HIF中确定了平行和区别在正常和癌细胞之间切换动态.

结论:

HIF开关是人类内皮细胞和癌细胞的基本生存机制.
了解HIF开关提供了有关癌细胞适应和潜在治疗策略的见解.
进一步的研究是有必要的,以区分正常和瘤细胞通路利用的向疗法.

关键词:

这就是EPAS1的原因.这就是HIF-1α.这就是HIF-2α.这就是HIF-3α.这就是HIF1A.如果HIF3A 人体内皮细胞是人体内皮细胞.氧气过低是因为缺氧.

更多相关视频

Induction and Testing of Hypoxia in Cell Culture

Induction and Testing of Hypoxia in Cell Culture

Published on: August 12, 2011

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Published on: June 14, 2024

相关概念视频

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

Mechanism of Angiogenesis

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Receptor Downregulation in MVBs

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...